Pyridostigmine
Pyridostigmine[edit]
Pyridostigmine[edit]
Pyridostigmine is a medication primarily used for the treatment of myasthenia gravis, a chronic autoimmune neuromuscular disease. It is also used in conjunction with atropine to reverse the effects of non-depolarizing neuromuscular blocking agents.
Overview[edit]
Pyridostigmine belongs to a class of drugs known as cholinesterase inhibitors. It enhances communication between nerves and muscles, improving muscle strength in patients with myasthenia gravis.
Uses[edit]
Myasthenia Gravis[edit]
Pyridostigmine is a cornerstone in the management of myasthenia gravis, helping to alleviate muscle weakness.
Neuromuscular Blockade Reversal[edit]
In anesthesia, pyridostigmine is used with atropine to terminate the effects of non-depolarizing neuromuscular blocking drugs.
Administration[edit]
Pyridostigmine can be administered orally or via injection. Oral administration is most common, with effects typically beginning within 45 minutes and lasting up to 6 hours.
History[edit]
Pyridostigmine was first patented in 1945 and introduced for medical use in 1955. Since then, it has become a vital medication in neurology and anesthesiology.
Global Availability[edit]
Listed on the World Health Organization's List of Essential Medicines, pyridostigmine is recognized as a critical medication in healthcare systems worldwide. It is available as a generic medication, ensuring broader accessibility.
 | This medical article is a stub. You can help WikiMD by expanding the page. |
